| Net sales | 777M |
| Cost of goods sold | 430.73M |
| Research and development expenses | 64.42M |
| Selling and administrative expenses | 152.05M |
| Restructuring and other charges, net | 0 |
| Interest expense | 13.11M |
| Other expense, net | -2.16M |
| Total cost and expense | |
| Income before taxes on income | 113.39M |
| Taxes on income | 23.61M |
| Net income | 89.78M |
| Foreign currency translation adjustments | |
| Gains (Losses) on derivatives qualifying as hedges | |
| Pension and postretirement net liability adjustment | |
| Comprehensive income | 86.44M |
| Net income per share - basic | 1.13 |
| Net income per share - diluted | 1.12 |
| Average number of shares outstanding - basic | 79.58M |
| Average number of shares outstanding - diluted | 79.94M |
| Dividends declared per share | 0.64 |